Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hagedoorn

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|November 16, 2002
Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosolsA H de Boer, D Gjaltema, P Hagedoorn, et al.
Expert Opinion on Drug Delivery|August 19, 2016
Dry powder inhalation: past, present and futureA H de Boer, P Hagedoorn, M Hoppentocht, et al.
International Journal of Pharmaceutics|July 5, 2003
Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalationA H de Boer, P Hagedoorn, D Gjaltema, et al.
International Journal of Pharmaceutics|October 28, 1999
Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizerP P Le Brun, A H de Boer, D Gjaltema, et al.
International Journal of Pharmaceutics|October 28, 1999
Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizerP P Le Brun, A H de Boer, D Gjaltema, et al.
International Journal of Pharmaceutics|April 9, 2005
A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalationA H de Boer, B H J Dickhoff, P Hagedoorn, et al.
International Journal of Pharmaceutics|July 7, 2019
Learning from Parkinson's patients: Usability of the Cyclops dry powder inhalerM Luinstra, V Isufi, L de Jong, et al.
Plos One|July 15, 2015
Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods?M Luinstra, A W F Rutgers, H Dijkstra, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 27, 2002
Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principleA H de Boer, P P H Le Brun, H G van der Woude, et al.
Plos One|August 5, 2022
Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteersY A de Reus, P Hagedoorn, M G G Sturkenboom, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|November 16, 2002
Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosolsA H de Boer, D Gjaltema, P Hagedoorn, et al.
Expert Opinion on Drug Delivery|August 19, 2016
Dry powder inhalation: past, present and futureA H de Boer, P Hagedoorn, M Hoppentocht, et al.
International Journal of Pharmaceutics|July 5, 2003
Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalationA H de Boer, P Hagedoorn, D Gjaltema, et al.
International Journal of Pharmaceutics|October 28, 1999
Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizerP P Le Brun, A H de Boer, D Gjaltema, et al.
International Journal of Pharmaceutics|October 28, 1999
Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizerP P Le Brun, A H de Boer, D Gjaltema, et al.
International Journal of Pharmaceutics|April 9, 2005
A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalationA H de Boer, B H J Dickhoff, P Hagedoorn, et al.
International Journal of Pharmaceutics|July 7, 2019
Learning from Parkinson's patients: Usability of the Cyclops dry powder inhalerM Luinstra, V Isufi, L de Jong, et al.
Plos One|July 15, 2015
Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods?M Luinstra, A W F Rutgers, H Dijkstra, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 27, 2002
Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principleA H de Boer, P P H Le Brun, H G van der Woude, et al.
Plos One|August 5, 2022
Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteersY A de Reus, P Hagedoorn, M G G Sturkenboom, et al.
Pageof 3